Search Login Register

pimecrolimus (Elidel) Summary

Description: an ascomycin derivative; mechanism of action involves calcineurin inhibition, blockage of T cell activation, blocking signal transduction pathways in T cells, and inhibition of the synthesis of inflammatory cytokines, specifically Th1- and Th2-type cytokines

Also Known As: Elidel; 33-epi-chloro-33-desoxyascomycin; ASM 981; Novartis brand of pimecrolimus; SDZ ASM 981 Show All >>

Networked: 502 relevant articles (142 outcomes, 153 trials/studies) for this Drug

Key Diseases for which pimecrolimus is Relevant

  1. Atopic Dermatitis (Atopic Eczema) : 56 outcomes 61 studies in 217 results
  2. Psoriasis (Pustulosis Palmaris et Plantaris) : 13 outcomes 9 studies in 33 results
  3. Dermatitis : 10 outcomes 7 studies in 31 results
  4. Eczema : 9 outcomes 12 studies in 37 results
  5. Pruritus (Itching) : 9 outcomes 10 studies in 46 results
Show All >>

Drugs Related to pimecrolimus

  1. pimecrolimus (Elidel)
  2. Tacrolimus (Prograf)
  3. Adrenal Cortex Hormones (Corticosteroids)
  4. Calcineurin
  5. Cytokines
  6. immunomycin (ascomycin)
  7. Clobetasol (Clobetasol Propionate)
  8. Betamethasone (Celestone)
  9. Hydrocortisone (Cortisol)
  10. Steroids
Show All >>

Therapies Related to pimecrolimus

  1. Off-Label Use
  2. Dye Lasers
  3. Stents
  4. Laminectomy
  5. Phototherapy (Light Therapy)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.